Market Intelligence chevron_right Pharma & Healthcare chevron_right Viral Vector-Based Gene Therapy
Global Report 2025

Global Viral Vector-Based Gene Therapy Market Growth (Status and Outlook) 2025-2031

calendar_todayPublished: Mar 2025 descriptionPages: 93 categoryCategory: Pharma & Healthcare
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount

The global Viral Vector-Based Gene Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of % from 2025 to 2031.

United States market for Viral Vector-Based Gene Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Viral Vector-Based Gene Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Viral Vector-Based Gene Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

This Insight Report provides a comprehensive analysis of the global Viral Vector-Based Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Viral Vector-Based Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Viral Vector-Based Gene Therapy market.

This report presents a comprehensive overview, market shares, and growth opportunities of Viral Vector-Based Gene Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type

  • Adenovirus (AdV)
  • Adeno-associated Virus (AAV)

Segmentation by Application

  • Hospital
  • Clinic
  • Others

Market by Region

  • Americas
  • APAC
  • Europe
  • Middle East & Africa

Company Coverage

  • Sibiono
  • Rigvir Group
  • Shanghai Pharma (Sunway)
  • Amgen
  • Spark Therapeutics
  • Novartis Gene Therapies
  • Daiichi Sankyo
  • PTC Therapeutics

Key Questions Addressed in this Report

Frequently Asked Questions

What is the USP of the report? expand_more
Viral Vector-Based Gene Therapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Viral Vector-Based Gene Therapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Viral Vector-Based Gene Therapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.